Inside Health

We investigate the growing business of full-body MRI scans. The clinics argue they can spot diseases and problems early before people feel unwell - but critics say it’s a waste of thousands of pounds and creates unnecessary anxiety about things that may never become a problem. Laura visits a clinic to learn more and also hears about the risks. Also this week, new research shows strokes are increasing among black African and black Caribbean people in the UK at a faster rate in than in white people - and it’s mainly being driven by high blood pressure. Laura meets Dr Iain Marshall, a GP who researches stroke risk factors, and Sheila Chingono, who had a stroke aged 32, to talk about why this is happening and what can be done to prevent it. And most of us hear the phrase ‘emergency food stockpile’ and think of a sad-looking kitchen cupboard full of tins we’d rather not eat. Laura speaks to a nutritional scientist about how you can still have a healthy and tasty meal with non-perishable goods, even if you’ve got…

Right now, research is gathering pace in revolutionising our understanding of inflammation, which could transform the treatment of so many chronic diseases - cancer, Alzheimer's, heart disease, depression, type 2 diabetes and many more. So, what is inflammation, how is it implicated in these diseases and can we do anything about it? Immunologist Professor Eleanor Riley at the University of Edinburgh explains what inflammation actually is and how chronic inflammation can get stuck in a self-perpetuating loop. We speak to Professor Charlie Swanton, who is the Francis Crick Institute’s Clinical Director. He explains how his research into inflammation is leading to a radical new approach to lung cancer-prevention. Professor Tara Spires-Jones, Director of the Centre for Discovery Brain Sciences at the University of Edinburgh, outlines the conundrum of inflammation in Alzheimer’s. We know it plays a key role, but how to intervene remains a mystery. And can we as individuals do anything to bring down inflammation?…

Insulin has been used to treat type 1 diabetes for more than a century but now there is a new treatment being rolled out on the NHS that can delay the onset of the disease for years. Alongside, screening is gathering pace, identifying those that could benefit. So, is this the beginning of a new era for type 1 diabetes treatment? Dima and his mum Elena explain what it was like to be told that he had tested positive for developing type 1 diabetes and what it was like taking part in the trial for this new drug, teplizumab. Parth Narendran, a Professor of Diabetes Medicine at the University of Birmingham, and Consultant Paediatric Endocrinologist Dr Renuka Dias at Birmingham Women's and Children's Hospital, reveal how these changes are transforming treatment. In July, the NHS announced plans to incentivise us to walk a marathon a month by offering vouchers and discounts. But with scant detail on how the plan will actually work, we ask Joan Costa-i-Font, Professor of Health Economics at London School of…

More than six years since the start of the Covid pandemic, it might feel like we're pretty over it, yet that's simply not the case for the millions of people who suffer from long Covid. But could there be hope on the horizon? A new clinical trial led by University College London and University College London Hospitals found that over-the-counter antihistamines and a prescription anti-inflammatory drug called colchicine offered a small reduction in fatigue for people with long Covid. But it's still not a cure. Professor Danny Altmann, an immunologist at Imperial College London, joins us to discuss this new research and the problems with understanding long Covid. He also tells us about some of the upcoming studies that might help us better get a handle on the condition. Also this week, did you know that around one in 335 people in the UK are living with a stoma? Yet according to Colostomy UK, more than 60 per cent of those with a stoma say a lack of suitable toilet facilities affects their daily lives. Thanks…

We’ve had two heatwaves already this summer with warnings that even young and healthy people should rethink their fitness routines in the heat. So how can we keep exercising when it’s so hot you barely want to move? James chats with physiologist Damian Bailey from the University of South Wales. Next, James is at Rother Valley Country Park in Sheffield to meet Calli Hauger-Thackery who made headlines for running the Boston marathon while 22 weeks pregnant and physiotherapist Ros Cooke to find out what changes in the body during pregnancy - and see what exercise is safe. So we’ve worked up a sweat… but what’s the best way to recover? We’re in the lab at the University of Westminster to put electrolytes to the test with Dr Lewis Mattin and we cool off with Ros Cooke while chatting about active recovery versus total rest. Presenter: James Gallagher Special appearance: Hannah Fisher Producer: Gerry Holt Editor: Ilan Goodman Production coordinator: Stu Laws

Earlier this summer, there was some incredible progress in cervical cancer. Women who have been vaccinated against the human papillomavirus (HPV) now have an almost zero chance of dying from cervical cancer before the age of 30. But does that mean women will no longer need cervical screening? Dr Jo Morrison, a consultant gynaecological oncologist from Somerset NHS Foundation Trust, joins James Gallagher and resident GP Dr Margaret McCartney to discuss. The government has announced school dinners will soon be overhauled in England, in order to reduce the amount of salt, sugar and fat, and boost the amount of fibre and nutrients offered to schoolchildren. James is joined by Dr Maria Traka, head of the food and nutrition national bioscience research infrastructure at the Quadram Institute in Norwich, to find out what the new dinners will look like. He also pays a visit to the Food Museum in Suffolk, where curator Katherine Bridges takes him on a trip through the decades, to see whether school dinners are…

An experimental treatment to “reset” the immune systems of people with autoimmune disease is showing transformative results in early trials. James visits the NIHR Clinical Research Facility in Manchester to meet Kathy. She was diagnosed with lupus just after the birth of her baby and in 2024 became the first person in the UK to try CAR-T therapy as part of a clinical trial. How is she feeling now? We’ll also hear from Kathy’s rheumatologist Professor Ben Parker, who led the trial Kathy took part in and explains how the therapy works, the astonishing early results - and whether the effects on the immune system are long lasting. Also this week, James visits the London School of Hygiene and Tropical Medicine to meet some lab-grown British mosquitoes and find out whether they’re out to get us for longer periods of the year and how worried we should be about the threat of disease, with medical entomologist Dr Mojca Kristan and virologist Professor Roger Hewson. And we look at the latest online trend of…

A new non-hormonal drug has been approved to treat menopausal hot flushes. It works by regulating the body's cooling signals and is now available on the NHS in England for those who cannot use hormone replacement therapy. Before delving into the evidence with resident GP Dr Margaret McCartney, James finds out what it feels like to have a hot flush. Also this week, James chats to Dr Manjula Meda, a microbiologist who is spearheading a radical new project. She has found that water systems in hospitals may be a breeding ground for antimicrobial resistance, and is tackling this by removing the sinks from wards. Is it effective and safe? Finally, we all do it, but we don't like discussing it... Farting. James speaks to the University of Maryland's Professor Brantley Hall, who has developed a 'fart detector' that can measure emissions to get a better understanding of gut health. And James gets the chance to attach one to his pants for three days. For science, of course. Presenter: James Gallagher Producer: Alice…

Little over a week on from the first meningitis cases in Canterbury, many crucial questions remain. So this week we're taking an in-depth look at those questions and what we’ve learnt from this outbreak - and could it happen again? James also hears from author Michael Rosen whose son Eddie died from meningitis aged 18 about just how quickly the disease struck and how he deals with his grief. And would you trust health advice from an AI chatbot? We hear from someone who regularly turns to ChatGPT and from GP Dr Margaret McCartney about her concerns. Presenter: James Gallagher Producer: Gerry Holt Content editor: Ilan Goodman Production coordinator: Stuart Laws Studio engineer: Donald MacDonald Inside Health was made by the BBC’s Audio Science Unit in collaboration with The Open University.

More than 30,000 people are being contacted in the Canterbury area regarding the outbreak of bacterial meningitis in Kent. Two people have died, and others are seriously ill. James Gallagher speaks with immunologist Sir Andrew Pollard about the disease, and finds out what could have caused the outbreak. That’s the major headline from the UK. But more broadly, for the last few weeks the news has been dominated by the situation in the Middle East. James speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe. And finally, James finds out about an ongoing trial at the University of Exeter, where interactive computer games are being used by stroke patients to improve their recovery. And, of course, James has a go himself! Presenter: James Gallagher Producer: Alice Lipscombe-Southwell…

There have been nearly 200 cases of measles in the UK so far this year. Measles can be prevented with vaccines - but the proportion of children being immunised is declining across the UK, particularly in parts of London. James visits Hackney, which has one of the lowest vaccination rates in the country, to find out why and to see what is happening to tackle this issue. And have you tried an adaptogenic drink? They claim to relax the mind, without giving you a boozy hangover. James samples some in the lab and then gets behind the wheel of a simulator to see what it does to his driving skills… Presenter: James Gallagher Producer: Gerry Holt Researcher: Thomas Hunt Editor: Ilan Goodman Production coordinator: Stuart Laws Sound engineer: Giles Aspen Inside Health was made by the BBC’s Audio Science Unit in collaboration with The Open University.

Penis fillers were an unexpected talking point at the recent Winter Olympics after claims that male ski jumpers were having them to improve performance. So this week we’re digging into the UK’s penis filler industry. James visits a private clinic in Manchester to hear about about the procedure, which involves hyaluronic acid being injected to temporarily increase penis girth. He meets Jason, who had his first penis filler five months’ ago, and he explains why he wanted it and how he weighed up the risks versus the benefits. James also chats to an NHS surgeon who says increasing numbers of men are seeking out the procedure - and he is dealing with the consequences when it goes wrong. Also this week, why is aspirin in short supply? Presenter: James Gallagher Producer: Gerry Holt Editor: Ilan Goodman Production coordinator: Stuart Laws Sound engineer: Emma Harth The show was made by the BBC’s Audio Science Unit in collaboration with The Open University.

ME – also known as Chronic Fatigue Syndrome – has long been one of medicine’s most perplexing conditions. With no definitive diagnostic test and a legacy of scepticism in parts of the medical community, patients have often struggled to be believed. But a surge of new research may finally be shifting the landscape. The emergence of Long COVID – a condition with striking similarities to ME – has accelerated scientific interest and opened new lines of inquiry into the underlying biology of both illnesses. In this episode, James Gallagher speaks to Dr Chris Ponting about the latest DecodeME results, which point to a strong genetic component to ME. And Professor Rosemary Boyton outlines the ambition behind the new Rosetta Stone study, designed to build a detailed evidence base of shared biomarkers across ME and Long COVID. James also hears from Catherine and Jo, who have lived with ME for many years. They describe their diagnostic journeys and how they manage their symptoms in their daily lives. Presenter: James…

Over 1.5million adults in the UK tried weight loss drugs in 2024-25. Many swear by them, but they have been associated with side effects including nausea and, in some cases, extremely painful gallstones. But what does the evidence actually tell us, and what is the wider impact on the way we view our bodies in society? James Gallagher is joined by Professor of Cardiometabolic Medicine at the University of Glasgow Naveed Sattar, Dr Beverley O’Hara, Lecturer in Public Health Nutrition at Leeds Beckett University, and Dr Margaret McCartney, resident Inside Health GP. They discuss what the evidence tells us about the potential known side effects of these weight loss drugs, and the potential impact their use has on our view of obesity as a society. We also hear from Sarah Le Brocq, who has struggled with obesity all her adult life and has been on these drugs for the past 2-3 years about her experiences. Margaret McCartney has no conflicts of interest to declare. Beverley O’Hara has no conflicts of interest to…

Dentistry is high on the public and political agenda. There have been dozens of headlines about access to NHS dentistry, with some people having to travel huge distances to find a dentist, or being put onto long waiting lists to get an NHS appointment. In this episode of Inside Health, James Gallagher is joined by chairman of the British Dental Association Eddie Crouch, the Oral Health Foundation's Dr Rachael England, and consultant oral surgeon Tom Thayer. Together, they drill into the issues surrounding NHS dentistry. Along the way, they discuss possible solutions, whether contract reforms will help, and the potential future of dentistry in the UK. Presenter: James Gallagher Producers: Alice Lipscombe-Southwell and Thomas Hunt Production coordinator: Stuart Laws Content editor: Ilan Goodman

Most of us have Epstein-Barr Virus (EBV) hiding in our bodies. You may know it as the cause of glandular fever or “kissing disease”. But more research is suggesting that it can turn our immune systems against us to cause autoimmune disease, such as multiple sclerosis or lupus. So, what is the virus doing in our bodies - and can we do anything about it? James is joined by Dr Claire Shannon-Lowe, a virologist at the University of Birmingham, and Dr Patrick Kearns from the University of Edinburgh, a neurologist and epidemiologist. And we delve into the world of echolocation. Bats hunt at night by making pulses of sounds and listening to the echoes so they can build a picture of the world around them in total darkness - and it's a technique some people with visual impairment use to explore the world. A team at the University of East Anglia has been testing how well humans can pick up these skills, so James pays a visit to have a go... Presenter: James Gallagher Producers: Gerry Holt, Tom Bonnett & Thomas Hunt…

This week we’re looking at government plans to start sequencing the DNA of every newborn baby in England within the next decade. Each newborn would undergo whole genome sequencing to assess their risk of hundreds of diseases, under NHS plans. It promises a revolution in spotting disease early - but are there also risks? And use of nicotine pouches is rising, especially among young men. But these little sachets that fit under the top lip aren’t yet regulated – so what do we know about the potential harms? Finally, as the cold weather continues, James gets a lesson in walking like a penguin to see if it helps avoid trips, slips and falls… Presenter: James Gallagher Producers: Tom Bonnett, Alice-Lipscombe-Southwell and Thomas Hunt Production coordinator: Stuart Laws Content editor: Ilan Goodman

James Gallagher stands by four lanes of traffic and inhales exhaust fumes all to see if he can see air pollution in his body. He looks at an intriguing finding that an mRNA vaccine might benefit people being treated with immunotherapy for some cancers and could we be on the cusp of a holy grail in dentistry? A breakthrough could mean we will soon be able to replace the enamel on our teeth. Presenter: James Gallagher Producer: Tom Bonnett Researcher: Thom Hunt Editor: Ilan Goodman

Saunas are popping up all over the country, with many people claiming they relax muscles and help ease stress. But what does the science say? This week, James Gallagher travels to Môr A Sawna in Jackson’s Bay, Barry, where he treats himself to a sauna session and undergoes a number of physical tests to find out what benefits the sweaty heat could offer. Next up, James visits The Advanced Neuropathies Centre in Cardiff to speak with Professor Liam Gray, a surgeon who is leading a pioneering treatment for Huntington’s disease. Presenter: James Gallagher Producers: Alice Lipscombe-Southwell and Gerry Holt Researcher: Tom Hunt Editor: Ilan Goodman Production coordinator: Stuart Laws This episode was produced in partnership with The Open University.

In 1964, the future for children born with Cystic Fibrosis was grim - most faced a life cut tragically short. Today, the majority of people living with CF in the UK are adults, a testament to extraordinary medical progress. We meet Annabelle who lives with Cystic Fibrosis, and once believed she might not see her 18th birthday. And we hear from Dr Imogen Felton, a respiratory consultant at Royal Brompton Hospital, with expertise in cystic fibrosis, who tells us about the therapies crucial to this extended prognosis. The EDITH trial (Early Detection using Information Technology in Health) is testing how AI can help radiologists identify breast cancer at an earlier stage, transforming the future of diagnosis. We speak to Professor Sian Taylor-Philips, Professor of Population Health at the University of Warwick and co-leader of the trial. In 2024, participation in Run Clubs across the UK surged by 64%. But does running in a group lead to better performance? To find out, James laces up for a jog around Hyde Park…

Dementia is now the UK’s leading cause of death - but could a vaccine one day help prevent it? New data from Wales suggests the shingles vaccine is linked to a 20% lower risk of developing dementia in later life, adding to evidence that viral infections can influence brain health. Dr. Pascal Geldsetzer, Assistant Prof of Medicine at Stanford University discusses his findings and the further evidence required to prove this link, along with Prof Tara Spires-Jones, Group Leader in the UK Dementia Research Institute. The UK has begun using the world’s first gonorrhoea vaccine - though it was originally developed for meningitis. With antibiotic-resistant strains increasing, we speak to Dr Suneeta Soni about why gonorrhoea has been so hard to target with vaccines. At the Bristol Robotics Lab, engineers are creating devices to support mobility in older age. James meets Jonathan Rossner and tries out “The Right Trousers” - an inflatable exoskeleton designed to help people walk and to strengthen their muscles.…

More and more parents are using melatonin to help their children sleep - but there is little research on the long-term effects. So, what do we know about the risks and is it ok to give it to children as an aid to help sleep? James chats to Paul Gringras, professor of children’s sleep medicine and neurodisability at Guy’s and St Thomas’ NHS Foundation Trust and Vicki Beevers, chief executive of The Sleep Charity. Also this week, resident GP Margaret McCartney on the potential promise - and peril - of doctors using AI in the NHS, and should you eat your placenta? We hear from a dietician on whether there’s any evidence it’s good for you. Presenter: James Gallagher Producers: Tom Bonnett, Debbie Kilbride & Gerry Holt Editor: Ilan Goodman Production coordinator: Ishmael Soriano This episode was produced in partnership with The Open University.

Drug-related deaths are at their highest levels in England and Wales since records began 30 years ago. Scotland has had the highest number of drug deaths in Europe for at least seven years. And the UK has even seen opioid-related deaths surpass the number of people dying in road traffic accidents. So today on Inside Health we’re asking, what's the real story behind these numbers? Who is dying of a drug overdose and why - and how can we tackle this issue? James Gallagher is joined by an expert panel, including: - Professor Catriona Matheson, Professor in Substance Use at the University of Stirling and former chair of Scotland’s drug deaths taskforce - Dr Caroline Copeland, Senior Lecturer in Pharmacology and Toxicology at King’s College London and Director of the National Programme on Substance Use Mortality - Dr Michael Blackmore, a GP in Grangemouth, central Scotland, who has a special interest in addictions and is himself a former drug addict, now 16 years in recovery We also visit Professor Sir John…

Exosomes are tiny balls of fat that allow cells to communicate with each other in our bodies. They're being actively researched as an experimental new type of medicine, and they're also being used in the cosmetics industry in serums, as well as being injected into people's skin. Researchers have raised concerns about the safety of this hot new trend in beauty. Presenter James Gallagher meets Dr James Edgar from the University of Cambridge who studies exosomes in his lab, he's also joined by consultant Kamal Kaur who advises the cosmetics industry on regulation around products containing exosomes, and we head to one of the UK's hot spots for beauty clinics and dermatology - the Marlyebone area of London - to meet consultant dermatologist in the NHS and One Wellbeck, Dr Ellie Rashid. Also in the programme, a new physio app is being trialled by the NHS. It's been rolled out to patients in Lothian in Scotland and we meet the people who have been using it, the real-life physio behind it and hear whether apps…

With bin strikes in Birmingham having gone on for months, James Gallagher heads to the Small Heath area of the city to ask what the health risks could be from rubbish left on the streets. He meets campaigners Shafaq, Ashid and Danni from End the Bin Strikes who tell him what residents are worried about. To discuss what diseases could be brewing and how they might spread, he's also joined by Professor Malcolm Bennett from the School of Veterinary Medicine and Science at the University of Nottingham and Martin Goldberg, Lecturer in Microbiology from Birmingham City University. Following news that a child who contracted measles has died at a hospital in Liverpool, James also talks to Professor of Children's Health Helen Bedford from University College London about the risk of measles in the UK. And, over the past week James has been reporting on the news that children have born using a technique which uses two women’s eggs and a man’s sperm to prevent mitochondrial disease being passed from mother to child. The…

As an era-defining summer of women’s sport kicks off, Inside Health looks at the science of sport and the female body. What do we know about how female physiology affects sporting performance? James visits Manchester to meet elite athletes and the scientists who are at the forefront of investigating the impact of periods on athletic performance and why women are more prone to certain injuries than men. He also hears about breast movement and why the right sports bra really matters. You'll hear from: - Calli Hauger-Thackery, a distance runner who has represented Team GB in the Olympics and Commonwealth Games; - Kirsty Elliott-Sale, Professor of Female Endocrinology and Exercise Physiology at Manchester Metropolitan University; - Dr Thomas Dos'Santos, Senior Lecturer in Strength and Conditioning and Sports Biomechanics at Manchester Metropolitan University; - Joanna Wakefield-Scurr, Professor of Biomechanics and Head of the Research Group in Breast Health at the University of Portsmouth; - Katy Daley-McLean,…

The Prime Minister has launched a 'new era' for the NHS that aims to move away from reactive care in hospitals to preventing illness through community services. It's an ambitious plan and one with a lot of ambition and a lot of unknowns. James Gallagher discusses the plans with Sarah Woolnough, Chief Executive of The King's Fund, an independent think tank working to improve health and care across England, and Sally Gainsbury, Senior Policy Analyst at the Nuffield Trust, specialising in evidence-based research on health and social care provision in the UK. Artificial Intelligence (AI) is being touted as a way to improve efficiency and save money in the 10 Year Plan and every day in healthcare there are headlines about new AI-driven tools that could revolutionise medicine. In a new mini-series, James hears about different ways AI is being used starting with heart scans that use AI to analyse large amounts of data to predict health outcomes in a way that would be near impossible for a human to achieve. He talks…

When the sun shines, out come the warnings that we all need to be careful in the sun to avoid burning and the risk of skin cancer. There are, though, those who believe that sort of public health messaging isn't positive enough about the benefits of the sun. As James Gallagher hears on the streets of Brighton, many of us know about the health benefits of vitamin d but new research suggests other benefits could be important for our health too. Should we working harder to get a balance of taking care in the sun but making sure we get enough exposure to it? James Gallagher looks at the evidence with Dr Richard Weller, Personal Chair of Medical Dermatology and Honorary Consultant Dermatologist at the University of Edinburgh, Dr Zoe Venables, a dermatologist with an interest in skin cancer epidemiology at Norfolk and Norwich University Hospitals, and Dr Margaret McCartney, GP, expert in evidence-based medicine. This episode is produced in partnership with The Open University. Presenter: James Gallagher Producer:…

What's the science behind a sweet tooth? James Gallagher explores whether sugar really can be addicted and what happens in our bodies when we want it and when we eat it. He's joined by Professor Susanne Dickson, who specialises in the neurobiology of appetite at the University of Gothenburg, and Professor James Brown from the School of Biosciences at Aston University. With Easter coming up, James meets dental hygienist and researcher Dr Claire McCarthy from King's College London in the BBC loos to get some top tips on keeping our teeth clean and gets a few pointers on where he could do with brushing up on his technique. Presenter: James Gallagher Producers: Tom Bonnett and Hannah Robins Assistant Producer: Anna Charalambou

We continue our exploration of some of the issues that could crop up if assisted dying becomes law under The Terminally Ill Adults (End of Life) Bill that is currently working its way through Parliament. Today we consider what those final moments might be like and if the ideal of a peaceful death is a reality with the drug options currently available. To discuss we're joined by: Katherine Sleeman - Professor of Palliative Care at King's College London David Nicholl - Consultant Neurologist at University Hospital Birmingham Mark Taubert - Consultant Palliative Medicine at NHS Wales Erica Borgstrom - Professor of Medical Anthropology at The Open University It's claimed that within each of us there is a credit card's worth of microplastics. We dig into the figures underlying that with Kit Yates, Professor of Mathematical Biology at the University of Bath. And, we answer your questions after our programme on hearing loss with audiologist Dr Hannah Cooper, Kevin Munro, Professor of Audiology at the University of…

We continue our exploration of some of the issues that could crop up if assisted dying becomes law under The Terminally Ill Adults End of Life Bill that is currently working its way through Parliament. Today we tackle safeguarding. How can we be certain an assisted death is what the person wants? And who should even bring up the conversation? To discuss we're joined by: Katherine Sleeman - Professor of Palliative Care at King's College London David Nicholl - Consultant Neurologist at University Hospital Birmingham Mark Taubert - Consultant Palliative Medicine at NHS Wales Erica Borgstrom - Professor of Medical Anthropology at The Open University Presenter: James Gallahgher Producers: Hannah Robins Assistant Production: Tom Bonnett and Siobhan

The Terminally Ill Adults End of Life Bill is working its way through Parliament. If it became law in England and Wales it would be one of those moments in history that profoundly changes society. There are similar discussions taking place in Scotland, the Isle of Man and Jersey too. To be clear about what we’re doing on Inside Health. We’re not going to debate the rights or wrongs of assisted dying. Or go through the politics of the Bill. Instead, over the next few episodes we’re going to explore some of the issues that will come up if assisted dying goes ahead. We’re going to start with eligibility and who could get an assisted death under the proposed rules? To discuss we're joined by: Katherine Sleeman - Professor of Palliative Care at King's College London David Nicholl - Consultant Neurologist at University Hospital Birmingham Mark Taubert - Consultant Palliative Medicine at NHS Wales Erica Borgstrom - Professor of Medical Anthropology at The Open University Also in the programme we have exclusive…

Five years on from the first Covid lockdown in the UK, we consider how the pandemic changed medicine. We're joined by Dr Emma Wall, academic consultant in Infectious Diseases at University College London Hospital who also runs a long covid clinic, Professor Katrina Pollock, Associate Professor in Vaccinology at the Oxford Vaccine Group and Jon Otter Director for Infection Prevention and Control at Guy’s Hospital London. Presenter: James Gallagher Producer: Hannah Robins

John is registered blind, and relies on his hearing to get around in his everyday life. But as he has got older, he’s started to notice his hearing deteriorate. He wants to know – is there anything available in between the initial solution of wax removal, and the final destination of hearing aids? He emailed Inside Health to ask James Gallagher to investigate. James speaks to Nish Mehta, an Ear, Nose and Throat surgeon at Royal National ENT Hospital, to find out how we hear, and learn about the different causes of hearing loss. He then visits UCL Ear Institute to undergo a hearing test with audiologist Dr Hannah Cooper, and see the potential future of hearing tests with Professor Maria Chait, an auditory cognitive neuroscientist. But hearing in day to day life is not as simple as in a science laboratory. James meets Kevin Munro, Professor of Audiology at the University of Manchester, in a noisy café to discuss hearing aid technologies and learn about their latest advancements. Presenter: James Gallagher…

Fitness trackers at the ready! Join James Gallagher at Cardiff Science Festival as he runs through the ways wearable tech is making an impact on health and how it might shape the future of medicines and care. With him are Dr Sanne Lugthart, Haematology consultant at the University Hospital of Bristol and Weston NHS Foundation Trust. She's pioneering using wearables and an app to track pain in people who suffer from sickle cell disease. Also on the panel is Professor Kathryn Peall who is Personal Chair, Division of Psychological Medicine and Clinical Neurosciences at Cardiff University. Kathryn tells James all about working with data from the UK Biobank to test if wearables could predict Parkinson's disease. She's also developing 80s-style headbands that could help take hospital grade sleep monitoring to the comfort of the bedroom. And, running experiments with the audience and on his skydiving assistant Danni, James is also joined by Damian Bailey, Professor of Physiology and Biochemistry from the University…

When we hit our teens it's often a time when everything starts to change. We meet new friends through work or studies, we start going out more at night and we're often in new situations independent from our parents. For people with severe allergies it can be a risky time because they have all this change in their life, on top of what Priya Matharu calls the 'full time job' of managing your condition. Presenter James Gallagher talks to Priya about her experience of having severe allergies from a young age and how she has coped with reactions that mean just touching her face after chopping a carrot has put her in hospital. For Priya, when she reached adolescence and moved out of her family it was a scary time and she had to grow up quickly to take responsibility for her allergies. In a recent debate in the House of Lords it was discussed that moving young people out of the paediatric allergy services they have grown up with the support of and into adult services, just as everything else in their life is…

Has James been buying shoes that are bad his feet? He meets podiatrist Dao Tunprasert to find out how healthy his shoes are. Also, returning to our theme of health conditions you find embarrassing, we get the lowdown on genital herpes from Dr Vanessa Apea. She's consultant physician in Genito-urinary and HIV medicine at Barts Health NHS Trust and an Honorary Senior Lecturer at Queen Mary University of London and answers some of your questions. Presenter: James Gallagher Producer: Tom Bonnett Assistant Producer: Siobhan Maguire

You sent in your questions on dementia and now we're tackling them. Professor Tara Spires-Jones, Director of the Centre for Discovery Brain Sciences at the University of Edinburgh, joins James Gallagher to go through the insidehealth@bbc.co.uk mailbag. James also visits mushroom grower the Bristol Fungarium which has teamed up with the University of the West of England to examine a mushroom called lion's mane. Lion's mane has a lot of hype about it online as well as a long history in traditional medicine and neuroscientist Dr Tim Craig and his team are taking it into their to lab to investigate whether it might harbour properties that could benefit people with dementia. Thanks to everyone who sent in questions after listening to our episode 'What next for Alzheimer's treatment' which is available on BBC Sounds: https://www.bbc.co.uk/programmes/m0024ng7 Presenter: James Gallagher Producer: Tom Bonnett Editor: Holly Squire

James Gallagher discusses the risk from H5N1 bird flu in the UK as a poultry worker in the West Midlands is infected and looks to the US where the disease is spreading in cattle. He's joined by virologist Dr Ed Hutchinson from the University of Glasgow to discuss how the virus is evolving, whether we are edging closer to bird flu becoming a pandemic and how it's being handled in the US as President Trump's government takes office. Also, you've been sending in your questions on embarrassing health problems and lots of you have asked about the problem of leaking urine, known as urinary incontinence. James puts your questions to Dr Vanessa Apea, a consultant physician in Genito-urinary and HIV medicine at Barts Health NHS Trust and an Honorary Senior Lecturer at Queen Mary University of London. Presenter: James Gallagher Producer: Tom Bonnett

Pasteurising milk makes it safer, but are there any benefits to drinking it “raw”? James heads to a dairy farm to investigate the evidence and see if anything is lost in pasteurising milk. Guests: Professor Marion Nestle, food policy expert, New York University Dr Ellen Evans, food safety expert at Cardiff Metropolitan University Jonny Crickmore, Fen Farm Dairy and chairman of the Raw Milk Producers Association Professor Markus Ege, researcher, University of Munich Presenter: James Gallagher Producer: Tom Bonnett

From kombucha to cold water swims, sleep to supplements, so many things are claimed to help enhance your immune system. We investigate the evidence, and ask if it's possible to avoid catching a virus this winter (and still leave the house). Plus, James braves 3.9 degree water to see for himself if cold water swimming has any affect on our immune systems. Guests: Margaret McCartney - Resident GP and expert in evidence-based medicine John Tregoning - Professor in Vaccine Immunology at Imperial College London Eleanor Riley - Professor of Immunology and Infectious Disease at University of Edinburgh Presenter: James Gallagher Producer: Hannah Robins Content Editor: Holly Squire The programme was produced in partnership with the Open University.

It has been a cold start to the year and for many that means the heating's on, windows are shut and we're drying clothes inside the house. For many people, mould becomes a major concern in winter and the health problems mould can cause have been under more scrutiny since the death of two-year-old Awaab Ishak who died in 2020 from long-term exposure to mould at his home in Rochdale. At Imperial College London a study called WellHome is underway to monitor levels of mould and other indoor pollutants in homes across the west of the capital. Presenter James Gallagher meets Mum of four Roxanne who had monitoring equipment installed in her house to collect data that could lead to guidance on housing quality and inform how healthcare professionals look for and treat conditions affected by mould. Joining James at Roxanne's is WellHome's Dr Athena Trachalaki, a Respiratory Registrar with Imperial College NHS trust. With her, to go through all the pollutants that pose a risk to our health indoors is WellHome lead and…

In the UK, around a third of British children have tooth decay. Just among the under-fives, it's a quarter - a figure that rises significantly in the most deprived areas. Tooth decay can cause speech development issues, embarrassment for children and in 2023, 15 million school days were missed due to tooth pain or treatment. There’s a financial cost too – in 2023 in England alone tooth extractions under a general anaesthetic cost the NHS £41 million. And it's totally preventable. So, how can we stop teeth rotting in the first place? One way initiative announced by the new Labour government is to expand supervised toothbrushing sessions to more children. We find out how these work with Oral Health Team Lead Helen Bullingham who supports nurseries and schools in East Sussex to deliver these programmes. But what about the evidence to support this intervention? Zoe Marshman, Professor of Dental Public Health at University of Sheffield, explains her findings and dental hygienist and researcher at King's College…

Olympic cyclist Sir Chris Hoy is calling for more prostate cancer testing after he was diagnosed with terminal cancer. Prostate cancer can often present without symptoms, and for people like Sir Chris, this can mean it isn't diagnosed until it has spread and become incurable. Unlike breast, bowel, or cervical cancer, there is currently no national screening programme that routinely invites men for prostate cancer testing. Instead, men over 50 can request what's known as a PSA blood test from their GP, but it's not automatically offered. Sir Chris wants that to change and is calling for the test to be made more easily available for men under 50, especially those with a family history of prostate cancer. But, expanding prostate screening is a divisive issue. While it could help detect cancer earlier in some cases, there are potential drawbacks. Inside Health's James Gallagher talks with Professor Frank Chinegwundoh, Consultant Urological Surgeon at Barts Health NHS Trust, Professor Hashim Ahmed, Chair of…

The first drugs to slow Alzheimer's progression have been making headlines around the world. For researchers in the field, the arrival of these two therapies called Lecanemab and Donanemab is testament to decades of advancements in the field of Alzheimer's research because for the first time they go further than modifying the symptoms and have been shown in trials to slow down cognitive decline. For patients and families these treatments offer hope that the amount of quality time they'll have together could be lengthened. Around the world regulatory bodies are weighing up their effectiveness, safety and cost. In the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Lecanemab and Donanemab for use but the National Institute for Health and Care Excellence (NICE) rejected them for use in the NHS on the basis the benefit to patients did not outweight the cost, although they could still be available privately. Presenter James Gallagher examines the decision with Professor of Public…

Have you ever thought about how you breathe? For many of us, the 20,000+ breaths we take each day go underneath our conscious awareness. But every now and then, a short-lived spout or a chronic case of breathlessness can remind us just how vital good breathing is for our health. But can we all breathe “better”? Some wellness trends suggest so... James Gallagher gets to grips with mouth-taping: the practice of taping the mouth shut during the night to promote exclusive ‘nasal breathing’. Many claim it has improved their sleep, their athletic performance and even given them a more chiselled jaw. Ken O’Halloran, professor of physiology at University College Cork, explains what research has been done looking into this trend and warns about when taping might do more harm than good. James also visits The Coliseum in Covent Garden to hear how an operatic training programme has improved the quality of life for people living with Long-COVID. ENO Breathe, designed by The English National Opera and Imperial College…

There are so many campaigns now to stop stigma and embarrassment - from Davina McCall talking about the menopause to Idris Elba campaigning for black men to get their prostate checked. And when we asked for your stories of how embarrassment impacts your health, our inbox was flooded with stories of incontinence, IBS, genital problems, skin issues, fertility troubles, fatty lumps and more - along with the huge and varied ways these issues are affecting your lives. So, how does embarrassment affect how we behave regarding our health, how can doctors and our health service adapt to alleviate it, and do awareness campaigns really help? To discuss James Gallagher is joined by: Dr Margaret McCartney, GP Dr Vanessa Apea, consultant in sexual health at Barts Health NHS Trust and Medical Director at Preventx Professor Ruth Parry, communications expert who studies clinician-patient interactions about sensitive issues. Plus, James gets some top tips to help alleviate embarrassment when talking to your doctor.…

If you have a rare genetic disorder, new technology that allows your genetic code to be analysed means you could have a diagnosis within weeks. Before, people with rare diseases would often go their entire lives without a diagnosis. It's a revolutionary advancement but does it change how patients are treated or help improve their wellbeing? Presenter James Gallagher meets Lisa whose daughter Jaydi was born with a rare genetic disease that affects her growth, speech, eyesight and a number of other conditions. We hear the story of Lisa and Jaydi's journey to diagnosis through Exeter University's Deciphering Developmental Disorders (DDD) study, and how it changed the course of Jaydi's life. Her clinician, Consulatant Clinical Geneticist Dr Emma Kivuva, tells James how the diagnosis impacted on the care they offered and Dr Caroline Wright, Genetics & Genomics Theme Lead on the DDD study explains how they are measuring the effect of diagnosis on patient treatment and wellbeing. This programme was produced in…

Trials of a cancer 'vaccine' have begun and presenter James meets Steve, one of the first patients to trial the new treatment, Steve remembers his shock at being diagnosed with colorectal cancer in his 40s and tells the story of how he became involved in this pioneering research into tackling cancer. The vaccine is based on the same mRNA technology as the Pfizer-BioNTech COVID-19 vaccine and James heads to the University of Cambridge to find out how the early work into cancer vaccines became the foundation for the rapid rollout of the covid vaccine. In the lab, molecular biologist Dr Anne Willis and immunologist Dr James Thaventhiran explain how the vaccine is personalised to target the unique make-up of an individual patients' cancer cells, and how if the trials are successful they could open the door to mRNA treatments being used to treat a wide range of diseases. Also, Imperial College London cyber security researcher Dr Saira Ghafur joins James in the studio to explain why healthcare is a growing target…

Mpox is spreading and it’s been classified a public health emergency by the World Health Organization. Presenter James Gallagher meets Professor Trudie Lang from the University of Oxford who has been working in the areas affected to discuss what it means for people in the countries it’s already reached and whether its spread can be stopped. James also puts your questions on statins to Professor Naveed Sattar, and we hear the story of Simon who works in the outdoors as a landscape manager. He was having bouts of severe illness and was struggling to understand what was behind it. The answer? He’d had successive bites from ticks and was having symptoms of an allergic reaction when he was eating meat. He had alpha gal syndrome, commonly known as a meat allergy. We hear how it’s caused debilitating changes to his life. We also hear from Consultant Immunologist Dr Rachael O’Brian who has been documenting the first case of alpha gal syndrome her team have been diagnosing at Frimley Park Hospital in Surrey.…